Lucira Health, Inc.
LHDXDelisted Apr 12, 2023- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001652724
Lucira Health, Inc. was delisted on Apr 12, 2023; its insiders filed their last Form 4 on Mar 13, 2023; 29 institutions reported holding it in 13F filings for Q4 2022, worth $1.04M in total; no superinvestor held it.
13F holders, Q3 2021
Institutional positions in Lucira Health, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 36
- −8 vs. Q2 2021
- Shares held
- 17.7M
- +1.48M (+9.1%) vs. Q2 2021
- Total value
- $131.9M
- +$23.9M (+22.2%) vs. Q2 2021
- New holders
- 10
- 13 more added
- Sold out
- 18
- 8 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LHDX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 1 | $321 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 1 | $545 |
| Q1 2023 | 6 | $1.46M |
| Q4 2022 | 29 | $1.04M |
| Q3 2022 | 28 | $24.2M |
| Q2 2022 | 38 | $42.2M |
| Q1 2022 | 40 | $83.7M |
| Q4 2021 | 46 | $211.6M |
| Q3 2021 | 36 | $131.9M |
| Q2 2021 | 44 | $107.9M |
| Q1 2021 | 51 | $233.6M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Lucira Health, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| EPIQ Capital Group, LLC | 13,796,183 | $104.9M | 10.84% | +502,733+3.8% | Added |
| Pura Vida Investments, LLC | 1,001,942 | $7.62M | 0.57% | +601,942+150.5% | Added |
| MPM Oncology Impact Management LP | 578,114 | $4.39M | 0.68% | +578,114 | New |
| Vanguard Group Inc | 448,454 | $3.41M | 0.00% | +20,500+4.8% | Added |
| Millennium Management LLC | 220,984 | $1.68M | 0.00% | +181,554+460.4% | Added |
| Silverarc Capital Management, LLC | 220,758 | $1.68M | 0.97% | +220,758 | New |
| Board of Trustees of The Leland Stanford Junior University | 124,459 | $946.0K | 0.07% | −252,246−67.0% | Reduced |
| Susquehanna International Group, LLP | 107,971 | $821.0K | 0.00% | +75,446+232.0% | Added |
| Foresite Capital Management V, LLC | 485,000 | $760.0K | 0.24% | 00.0% | Unchanged |
| Balyasny Asset Management LLC | 93,439 | $710.0K | 0.00% | +57,224+158.0% | Added |
| Geode Capital Management, LLC | 84,087 | $639.0K | 0.00% | −10,586−11.2% | Reduced |
| Wells Fargo & Company | 80,881 | $614.0K | 0.00% | −273−0.3% | Reduced |
| FMR LLC | 57,684 | $438.0K | 0.00% | +57,684 | New |
| BlackRock Inc. | 54,161 | $412.0K | 0.00% | +25,913+91.7% | Added |
| Citadel Advisors LLC | 51,382 | $391.0K | 0.00% | +51,382 | New |
| State Street Corp | 49,500 | $376.0K | 0.00% | +9,800+24.7% | Added |
| Ieq Capital, LLC | 46,175 | $351.0K | 0.01% | 00.0% | Unchanged |
| Papp L Roy & Associates | 45,850 | $348.0K | 0.04% | +45,850 | New |
| Federated Hermes, Inc. | 27,487 | $209.0K | 0.00% | −47,513−63.4% | Reduced |
| Resolute Partners Group | 22,800 | $173.0K | 0.02% | +22,800 | New |
| Northern Trust Corp | 17,414 | $132.0K | 0.00% | −1,742−9.1% | Reduced |
| Ergoteles LLC | 15,331 | $117.0K | 0.00% | −27,167−63.9% | Reduced |
| Cypress Point Wealth Management, LLC | 14,177 | $108.0K | 0.08% | +2,000+16.4% | Added |
| TrinityPoint Wealth, LLC | 14,250 | $108.0K | 0.02% | +2,250+18.8% | Added |
| Morgan Stanley | 13,973 | $105.0K | 0.00% | +1,925+16.0% | Added |
| Needham Investment Management LLC | 13,672 | $104.0K | 0.01% | 00.0% | Unchanged |
| ETF Managers Group, LLC | 14,130 | $104.0K | 0.00% | +2,750+24.2% | Added |
| Royal Bank of Canada | 11,660 | $89.0K | 0.00% | +10,999+1,664.0% | Added |
| Price T Rowe Associates Inc | 10,200 | $78.0K | 0.00% | −4,600−31.1% | Reduced |
| Johnson Financial Group, Inc. | 10,000 | $76.0K | 0.01% | +10,000 | New |
| Cutler Group LP | 1,400 | $10.0K | 0.00% | +1,400 | New |
| UBS Group AG | 1,147 | $9.00K | 0.00% | −1,276−52.7% | Reduced |
| Captrust Financial Advisors | 319 | $2.00K | 0.00% | 00.0% | Unchanged |
| Signaturefd, LLC | 215 | $2.00K | 0.00% | +215 | New |
| Simplex Trading, LLC | 43 | $0 | 0.00% | 00.0% | Unchanged |
| US Bancorp | 40 | $0 | 0.00% | +40 | New |
| JS Capital Management LLC | 0 | $0 | 0.00% | −400,000−100.0% | Sold out |
| Parian Global Management LP | 0 | $0 | 0.00% | −84,037−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −36,397−100.0% | Sold out |
| Tibra Equities Europe Ltd | 0 | $0 | 0.00% | −34,400−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −30,878−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −23,544−100.0% | Sold out |
| Paloma Partners Management Co | 0 | $0 | 0.00% | −19,312−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −13,110−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −10,293−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −4,402−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −2,085−100.0% | Sold out |
| Gemmer Asset Management LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −234−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Howe & Rusling Inc | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −96−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −10−100.0% | Sold out |